Virtual Adcom Vet Says In-Person Events May Be Better For Product Approval Recommendations

Syndax CEO also says US FDA’s virtual meetings would benefit from having advisory committee members on camera, which may be a technology challenge.

FDA Advisory Committee Feature image
The FDA said enabling webcams for advisory committee members may be problematic because of connectivity problems. • Source: Illustration

Briggs Morrison, a veteran of in-person and now virtual US Food and Drug Administration advisory committee meetings, believes an in-person event may be better when a product’s approval is on the agenda.

Morrison is CEO of Syndax Pharmaceuticals, Inc., a clinical-stage company focused on cancer therapies, and was among the first...

More from US FDA Performance Tracker

More from Regulatory Trackers